Hagopian Henry III 4
4 · Organogenesis Holdings Inc. · Filed Jan 15, 2021
Insider Transaction Report
Form 4
Hagopian Henry III
Interim CFO
Transactions
- Award
Stock Option (Right to Buy)
2021-01-13+64,198→ 64,198 totalExercise: $7.34Exp: 2031-01-13→ Class A Common Stock (64,198 underlying) - Award
Class A Common Stock
2021-01-13+10,700→ 12,073 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years from the date of grant.
- [F2]The option becomes exercisable in equal yearly installments over four years from the date of grant.